Assertio Holdings Inc (ASRT)
1.01
+0.09
(+9.64%)
USD |
NASDAQ |
May 02, 16:00
1.00
-0.01
(-0.99%)
After-Hours: 20:00
Assertio Holdings Enterprise Value: 60.71M for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 60.71M |
| May 01, 2024 | 52.28M |
| April 30, 2024 | 48.85M |
| April 29, 2024 | 45.32M |
| April 26, 2024 | 43.44M |
| April 25, 2024 | 39.35M |
| April 24, 2024 | 46.99M |
| April 23, 2024 | 51.16M |
| April 22, 2024 | 46.96M |
| April 19, 2024 | 38.20M |
| April 18, 2024 | 36.39M |
| April 17, 2024 | 38.86M |
| April 16, 2024 | 40.35M |
| April 15, 2024 | 42.13M |
| April 12, 2024 | 47.24M |
| April 11, 2024 | 48.58M |
| April 10, 2024 | 50.04M |
| April 09, 2024 | 50.95M |
| April 08, 2024 | 52.43M |
| April 05, 2024 | 54.80M |
| April 04, 2024 | 52.47M |
| April 03, 2024 | 52.57M |
| April 02, 2024 | 53.06M |
| April 01, 2024 | 53.67M |
| March 28, 2024 | 55.89M |
| Date | Value |
|---|---|
| March 27, 2024 | 58.81M |
| March 26, 2024 | 61.66M |
| March 25, 2024 | 63.56M |
| March 22, 2024 | 63.56M |
| March 21, 2024 | 64.51M |
| March 20, 2024 | 63.56M |
| March 19, 2024 | 60.71M |
| March 18, 2024 | 63.56M |
| March 15, 2024 | 71.16M |
| March 14, 2024 | 68.31M |
| March 13, 2024 | 73.06M |
| March 12, 2024 | 60.71M |
| March 11, 2024 | 53.56M |
| March 08, 2024 | 51.37M |
| March 07, 2024 | 51.37M |
| March 06, 2024 | 49.31M |
| March 05, 2024 | 49.05M |
| March 04, 2024 | 48.31M |
| March 01, 2024 | 48.31M |
| February 29, 2024 | 48.44M |
| February 28, 2024 | 44.97M |
| February 27, 2024 | 43.98M |
| February 26, 2024 | 42.69M |
| February 23, 2024 | 42.39M |
| February 22, 2024 | 40.97M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.500M
Minimum
Apr 03 2020
743.48M
Maximum
May 07 2019
205.64M
Average
142.07M
Median
May 13 2022
Enterprise Value Benchmarks
| Ocular Therapeutix Inc | 750.82M |
| Cormedix Inc | 219.22M |
| Verastem Inc | 164.89M |
| Puma Biotechnology Inc | 241.86M |
| CytomX Therapeutics Inc | 129.50M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -57.38M |
| Revenue (Quarterly) | 32.98M |
| Total Expenses (Quarterly) | 39.48M |
| EPS Diluted (Quarterly) | -0.32 |
| Gross Profit Margin (Quarterly) | 70.53% |
| Profit Margin (Quarterly) | -174.0% |
| Earnings Yield | -364.4% |
| Operating Earnings Yield | 21.33% |
| Normalized Earnings Yield | -117.01 |